Siglec‐7 ligands were predominantly found on the EpCAM+ tumor cells and to a lesser extent on tumor stroma, whereas Siglec‐9 ligands were expressed on both the EpCAM+ tumor cells and also highly on the tumor stroma. This evidence concerns the gene SIGLEC9 and neoplasm.